Dr. Jocelyn Elaine Ray, MD, PhD

Dr. Ray practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Ray's NPI, 1790139269, was assigned on April 20, 2016. Dr. Ray holds Illinois license 036157504.

Dr. Ray's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Ray's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Ray is also affiliated with Advocate Good Shepherd Hospital. The medical group on file is Rush University Internists. Dmand AI also links Dr. Ray to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ray practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Ray's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Ray is licensed in Illinois.

CMS data shows 74 Medicare services from Dr. Ray across 3 procedure codes in 2024, all of them office visits, for 52 Medicare patients. Medicare paid $7,791 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Dr. Ray in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ray's median patient age at 68, with 100% women.

In 2024, Dr. Ray wrote 67 Medicare Part D claims for 24 patients. 99% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $334,806 in total drug cost. In 2022, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Ray for performance year 2024, reported as part of a group. Dr. Ray accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ray as offering telehealth. CMS counts 18 procedures of removal of the uterus by Dr. Ray, more than 91% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Ray, published from 2020 to 2021. 2020 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Imidazoles and Pyridines. Dr. Ray's most frequent co-authors are Robyn M. Borsuk, MD, Kerry S. Campbell and Wen-I Wendy Chang, MD.

CMS Open Payments shows 20 general payments to Dr. Ray from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Intuitive Surgical, Inc. paid the most, $535.